Comparison of Budesonide, Symbicort and Triple Nebulized Drugs in Improving Perioperative Airway Function of Chronic Sinusitis

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048845

Enrollment

Unknown

Registered

2021-07-18

Start date

2021-07-15

Completion date

Unknown

Last updated

2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic nasosinusitis

Interventions

experimental group 1:Budesonide

experimental group 2:Symbicort

experimental group 3:Triple Nebulized Drugs

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients who meet the diagnostic criteria for chronic sinusitis and have abnormal lung function.

Exclusion criteria

Exclusion criteria: 1.Patients with lower airway diseases.

Design outcomes

Primary

Measure	Time frame
lung function;	—

Countries

China

Contacts

Public ContactZhang Yu

Yantai Yuhuangding Hospital

yangyujuanyyj@163.com+86 13792527677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026